MML Investors Services
PACB icon

MML Investors Services’s Pacific Biosciences PACB Stock Holding History

MML Investors Services’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,600
Closed -$30K – 2862
2025
Q1 		$30K Sell
25,600
-3,967
-13% -$6.08K ﹤0.01% 2670
2024
Q4 		$54K Buy
29,567
+8,239
+39% +$16.1K ﹤0.01% 2632
2024
Q3 		$36K Hold
21,328
– – ﹤0.01% 2546
2024
Q2 		$29K Buy
21,328
+8,989
+73% +$18.2K ﹤0.01% 2454
2024
Q1 		$46K Buy
12,339
+935
+8% +$5.47K ﹤0.01% 2449
2023
Q4 		$112K Sell
11,404
-105,186
-90% -$860K ﹤0.01% 2378
2023
Q3 		$974K Buy
116,590
+44,799
+62% +$512K 0.01% 1238
2023
Q2 		$955K Buy
+71,791
New +$872K 0.01% 1245

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

MML Investors Services's PACB Position: Q2 2025 in Review

MML Investors Services sold out of Pacific Biosciences (PACB) in Q2 2025, closing a stake of 25,600 shares — an estimated $30K sold.

MML Investors Services first reported a position in PACB in Q2 2023 and held it in 8 quarters. The position peaked at $974K in Q3 2023. 207 funds tracked by Wall St. Rank hold PACB as of Q2 2025.

  • MML Investors Services reported no remaining Pacific Biosciences position as of Q2 2025 after selling out during the quarter.
  • MML Investors Services sold 25,600 Pacific Biosciences shares in Q2 2025, an estimated $30K.
  • MML Investors Services first reported a position in Pacific Biosciences in Q2 2023 and held it in 8 quarters.
  • MML Investors Services's Pacific Biosciences position peaked at $974K in Q3 2023.
  • 207 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2025.

Based on MML Investors Services's 13F filing for Q2 2025, filed 14 Aug 2025.